Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Antidepressant utilization in Canada.

Beck CA, Patten SB, Williams JV, Wang JL, Currie SR, Maxwell CJ, El-Guebaly N.

Soc Psychiatry Psychiatr Epidemiol. 2005 Oct;40(10):799-807.

PMID:
16179967
2.

Epidemiology of antidepressant medication use in the Canadian diabetes population.

Ivanova A, Nitka D, Schmitz N.

Soc Psychiatry Psychiatr Epidemiol. 2010 Sep;45(9):911-9. doi: 10.1007/s00127-009-0129-y.

PMID:
19730761
3.

Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety.

Schaffer A, Cairney J, Veldhuizen S, Cheung A, Levitt A.

J Clin Psychiatry. 2007 Nov;68(11):1785-92.

PMID:
18052573
4.

Descriptive epidemiology of major depressive disorder in Canada in 2012.

Patten SB, Williams JV, Lavorato DH, Wang JL, McDonald K, Bulloch AG.

Can J Psychiatry. 2015 Jan;60(1):23-30. Erratum in: Can J Psychiatry. 2015 Mar;60(3):95.

5.

The utilization of antidepressants and benzodiazepines among people with major depression in Canada.

Sanyal C, Asbridge M, Kisely S, Sketris I, Andreou P.

Can J Psychiatry. 2011 Nov;56(11):667-76.

PMID:
22114921
6.

Frequency of antidepressant use in relation to recent and past major depressive episodes.

Patten SB, Wang JL, Williams JV, Lavorato DH, Beck CA, Bulloch AG.

Can J Psychiatry. 2010 Aug;55(8):532-5.

PMID:
20723281
7.

The public health impact of antidepressants: an instrumental variable analysis.

Mojtabai R.

J Affect Disord. 2011 Nov;134(1-3):188-97. doi: 10.1016/j.jad.2011.05.037. Epub 2011 Jun 17.

PMID:
21684009
8.

Progress against major depression in Canada.

Patten SB.

Can J Psychiatry. 2002 Oct;47(8):775-80.

PMID:
12420657
9.

Adjustment to antidepressant utilization rates to account for depression in remission.

Beck CA, Patten SB.

Compr Psychiatry. 2004 Jul-Aug;45(4):268-74.

PMID:
15224269
10.
11.

Antidepressant treatment of depression in the Finnish general population.

Laukkala T, Isometsä E, Hämäläinen J, Heikkinen M, Lindeman S, Aro H.

Am J Psychiatry. 2001 Dec;158(12):2077-9.

PMID:
11729032
12.

Psychotropic medication use in Canada.

Beck CA, Williams JV, Wang JL, Kassam A, El-Guebaly N, Currie SR, Maxwell CJ, Patten SB.

Can J Psychiatry. 2005 Sep;50(10):605-13.

PMID:
16276851
13.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
14.
15.

Descriptive epidemiology of major depression in Canada.

Patten SB, Wang JL, Williams JV, Currie S, Beck CA, Maxwell CJ, El-Guebaly N.

Can J Psychiatry. 2006 Feb;51(2):84-90.

PMID:
16989107
16.

Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.

Fisch MJ, Zhao F, Manola J, Miller AH, Pirl WF, Wagner LI.

Psychooncology. 2015 May;24(5):523-32. doi: 10.1002/pon.3606. Epub 2014 Jun 14.

17.
18.

Recall of recent and more remote depressive episodes in a prospective cohort study.

Patten SB, Williams JV, Lavorato DH, Bulloch AG, D'Arcy C, Streiner DL.

Soc Psychiatry Psychiatr Epidemiol. 2012 May;47(5):691-6. doi: 10.1007/s00127-011-0385-5. Epub 2011 May 1.

PMID:
21533819
19.

Weight gain in relation to major depression and antidepressant medication use.

Patten SB, Williams JV, Lavorato DH, Khaled S, Bulloch AG.

J Affect Disord. 2011 Nov;134(1-3):288-93. doi: 10.1016/j.jad.2011.06.027. Epub 2011 Jul 19.

PMID:
21774992
20.

[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].

Norton J, de Roquefeuil G, David M, Boulenger JP, Ritchie K, Mann A.

Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018. French.

Supplemental Content

Support Center